Autocrine HBEGF expression promotes breast cancer intravasation, metastasis and macrophage-independent invasion in vivo.
about
Traversing the basement membrane in vivo: a diversity of strategiesImmune cell promotion of metastasisMMTV-cre;Ccn6 knockout mice develop tumors recapitulating human metaplastic breast carcinomas.Regulation of invadopodia by the tumor microenvironment.The ErbB4 CYT2 variant protects EGFR from ligand-induced degradation to enhance cancer cell motility.Epiregulin contributes to breast tumorigenesis through regulating matrix metalloproteinase 1 and promoting cell survival.PTP1B-dependent regulation of receptor tyrosine kinase signaling by the actin-binding protein Mena.Role of EGFR expression levels in the regulation of integrin function by EGF.EGFR regulates the development and microarchitecture of intratumoral angiogenic vasculature capable of sustaining cancer cell intravasation.Uterine overdistention induces preterm labor mediated by inflammation: observations in pregnant women and nonhuman primates.Serotonin 6 receptor controls Alzheimer's disease and depressionDigging a little deeper: the stages of invadopodium formation and maturation.Adult stem cell lineage tracing and deep tissue imaging.Immunosuppressive cells in tumor immune escape and metastasis.The heparin-binding domain of HB-EGF as an efficient cell-penetrating peptide for drug delivery.Annexin A2 and its downstream IL-6 and HB-EGF as secretory biomarkers in the differential diagnosis of Her-2 negative breast cancer.A four gene signature predictive of recurrent prostate cancer.Tumor cell intravasation.Gene expression profiling of tumor-initiating stem cells from mouse Krebs-2 carcinoma using a novel marker of poorly differentiated cellsTissue-engineered 3D microvessel and capillary network models for the study of vascular phenomena.Invadosomes are coming: new insights into function and disease relevance.The Arkadia-ESRP2 axis suppresses tumor progression: analyses in clear-cell renal cell carcinomaMouse models of metastasis: progress and prospects.Tumor p38MAPK signaling enhances breast carcinoma vascularization and growth by promoting expression and deposition of pro-tumorigenic factors.The immune system in cancer metastasis: friend or foe?EGF receptor signaling, phosphorylation, ubiquitylation and endocytosis in tumors in vivo.Contact guidance diversity in rotationally aligned collagen matrices.Rac3 regulates breast cancer invasion and metastasis by controlling adhesion and matrix degradation.Mitosis-Mediated Intravasation in a Tissue-Engineered Tumor-Microvessel Platform.Myosin phosphorylation on stress fibers predicts contact guidance behavior across diverse breast cancer cells.ECM Cross-Linking Regulates Invadopodia Dynamics.Matricellular CCN6 (WISP3) protein: a tumor suppressor for mammary metaplastic carcinomas.Targeting invadopodia-mediated breast cancer metastasis by using ABL kinase inhibitors.EGFR signaling patterns are regulated by its different ligands.Cortactin and fascin-1 regulate extracellular vesicle release by controlling endosomal trafficking or invadopodia formation and function
P2860
Q26824769-49FBACDC-3C8F-486F-AD5B-91678304611BQ26991724-E2072CE5-97AE-4F4C-8A2B-C21D6CCF5082Q33585917-6B9CE1CD-6EEC-4A4B-8905-19EE8E6E738BQ34344630-971DDE1D-C67D-4A22-A83C-8C86B7CD4C1AQ35228445-AD0C02F1-EB8B-4A68-9806-C6AD3EC9CBE9Q35895967-D591B028-F3B6-4AE5-BF3D-C7122BF62725Q36224594-EE3A0235-FCC4-4ECE-A784-197E88BDC554Q36348380-E58BF580-5606-4420-A54E-63018C2732F9Q36360133-BA4AC317-C423-41EE-A4B8-A6BE0A2E5173Q36372512-F746ABE2-422E-4C7C-871D-98A4372FFFA6Q36413592-B94D1FDB-62E1-4525-AA46-58FAFAE01F4DQ38239028-F81AB08F-7787-4905-8A1F-9349FCC93ADAQ38658521-717CCD1C-4049-48F8-9BA8-C44468DB7102Q38675140-E2698099-9F42-4193-88E1-D09E2F7D69B1Q38741254-2D854BAD-694E-4E08-85C5-F7EF61EF7D02Q38753533-27467A0D-1554-4440-9FF6-34065E7BEDF4Q38783018-D70F3537-5DEC-4AC5-B98C-C21C8EEB991FQ38807918-BD07113D-3093-4357-A975-6BAFD2FB330BQ39056377-015A2B91-ADEC-480D-A691-EE86E549CE67Q39121501-A33C0B61-519D-49C3-8388-E6599AD36DDFQ39332459-363332EA-7F85-4C5F-8C6F-C1AAB91281C9Q40368929-BB1F5AA4-3DA4-4591-9790-FAA050B39D43Q41664785-C08B7C79-A0A4-492B-86E8-2416CB1F0DD1Q42252540-6D76F3F0-39DA-4CCE-A936-36AEC66B4E5CQ42656251-758A1C6E-073A-4833-B1D6-D0F565E1480EQ47156089-B64C6DD2-EE1D-4771-8F1F-3A2280FB1E5DQ47292429-F459A73D-A740-4A90-B383-45AB0D0175D7Q47614425-BC20703F-52A9-49D4-BDF9-664258F5CA0CQ47661828-B5D9C718-11EC-4B2D-A623-5EA8F117C65CQ51063526-CD803FB0-E96A-4D87-9DFA-7C4C9CA0D36FQ52625345-8B0D620E-A172-4491-A59F-65784233C919Q52709107-6E20A651-0ECB-4AB4-A21B-6A305FEF4BEDQ54978819-333C9D88-50A4-4879-9893-991E9ECE9990Q55070997-0638275D-7E40-4B32-9E9C-F1A4AE8AE0C4Q57799929-1EDD7897-30A6-489F-9EFD-25DBB704D2D4
P2860
Autocrine HBEGF expression promotes breast cancer intravasation, metastasis and macrophage-independent invasion in vivo.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Autocrine HBEGF expression pro ...... -independent invasion in vivo.
@en
Autocrine HBEGF expression pro ...... -independent invasion in vivo.
@nl
type
label
Autocrine HBEGF expression pro ...... -independent invasion in vivo.
@en
Autocrine HBEGF expression pro ...... -independent invasion in vivo.
@nl
prefLabel
Autocrine HBEGF expression pro ...... -independent invasion in vivo.
@en
Autocrine HBEGF expression pro ...... -independent invasion in vivo.
@nl
P2093
P2860
P356
P1433
P1476
Autocrine HBEGF expression pro ...... -independent invasion in vivo.
@en
P2093
E A Peterson
J E Segall
J S Condeelis
M Roh-Johnson
N Van Rooijen
P2860
P2888
P304
P356
10.1038/ONC.2013.363
P407
P577
2013-09-09T00:00:00Z